aTyr Pharma Inc. (ATYR)
undefined
undefined%
At close: undefined
4.00
1.39%
After-hours Jan 06, 2025, 07:41 PM EST

Balance Sheet (Annual)

Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12
Cash & Equivalents 22.54M 9.98M 2.34M 16.95M 9.21M 22.96M 21.09M 38.39M 53.02M 13.90M 36.46M 3.67M
Short-Term Investments 75.62M 56.16M 105.58M 14.74M 21.93M 26.58M 64.03M 33.76M 42.51M 1.95M n/a n/a
Long-Term Investments 3.48M 3.17M n/a n/a n/a n/a n/a 4.00M 29.81M n/a n/a 69.00K
Other Long-Term Assets 131.00K 193.00K 158.00K 213.00K 172.00K 90.00K 90.00K 333.00K 118.00K 2.21M 260.00K 331.00K
Receivables 2.44M 11.78M 435.00K 2.04M n/a n/a n/a n/a n/a n/a n/a n/a
Inventory n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets 2.39M 2.95M 5.22M 1.80M 681.00K 1.26M 1.87M 2.62M 2.42M 656.00K 564.00K 816.00K
Total Current Assets 102.99M 80.87M 113.57M 35.53M 31.93M 50.80M 86.98M 74.77M 97.95M 16.51M 37.02M 4.49M
Property-Plant & Equipment 14.05M 11.56M 1.81M 2.98M 4.09M 1.85M 2.28M 1.42M 1.79M 1.93M 2.50M 2.58M
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 17.66M 14.91M 1.97M 3.19M 4.26M 1.94M 2.37M 5.76M 31.73M 4.13M 2.77M 2.98M
Total Assets 120.65M 95.79M 115.54M 38.73M 36.19M 52.75M 89.36M 80.52M 129.68M 20.64M 39.79M 7.47M
Account Payables 3.53M 3.11M 1.03M 1.43M 847.00K 1.04M 2.28M 2.61M 3.87M 1.43M 1.05M 593.00K
Deferred Revenue n/a n/a 1.00 n/a 208.00K n/a n/a 130.00K n/a n/a n/a 255.00K
Short-Term Debt 1.33M 894.00K 980.00K 861.00K 9.49M 7.77M 5.01M 339.00K 3.37M 5.13M 728.00K 875.00K
Other Current Liabilities 11.56M 9.86M 4.00M 3.57M 3.48M 2.03M 3.10M 5.58M 4.91M 3.55M 3.42M 1.81M
Total Current Liabilities 16.42M 13.86M 6.01M 5.86M 12.92M 10.83M 10.39M 8.53M 12.15M 10.11M 5.21M 3.53M
Long-Term Debt 13.77M 10.64M 398.00K 1.38M 2.24M 8.26M 14.72M 9.20M 1.78M 5.14M 6.16M 3.67M
Other Long-Term Liabilities n/a n/a n/a n/a n/a n/a n/a n/a 701.00K 96.40M 94.50M 512.00K
Total Long-Term Liabilities 13.77M 10.64M 398.00K 1.38M 2.24M 8.26M 14.72M 9.20M 2.48M 101.54M 100.66M 5.20M
Total Liabilities 30.18M 24.50M 6.41M 7.24M 15.16M 19.10M 25.11M 17.72M 14.63M 111.65M 105.87M 8.73M
Total Debt 15.10M 11.53M 1.38M 2.24M 11.73M 16.03M 19.73M 9.54M 5.14M 10.28M 6.89M 4.54M
Common Stock 63.00K 29.00K 28.00K 11.00K 4.00K 31.00K 30.00K 24.00K 24.00K 1K 1K 6.00K
Retained Earnings -468.02M -417.63M -372.30M -338.53M -322.30M -298.70M -264.19M -215.98M -158.12M -110.15M -85.80M -64.52M
Comprehensive Income -74.00K -433.00K -263.00K -43.00K -40.00K -60.00K -120.00K -76.00K -171.00K -69.00K -69.00K n/a
Shareholders Equity 90.66M 71.46M 109.30M 31.65M 21.19M 33.65M 64.25M 62.80M 115.05M -91.01M -68.50M -1.28M
Total Investments 79.11M 59.33M 105.58M 14.74M 21.93M 26.58M 64.03M 37.76M 72.32M 1.95M n/a 69.00K